| BIOCRYST PHARMACEUTICALS |
| USA |
| Gesundheit |
| US09058V1035 / 896047 |
| BO1 (Frankfurt) / BCRX (NASDAQ) |
| FRA:BO1, ETR:BO1, BO1:GR, NASDAQ:BCRX |
| - |
| https://www.biocryst.com/ |
|
BioCryst Pharmaceuticals Inc. is a biotechnology company that focuses on the discovery and development of novel, oral, small-molecule medicines intended to treat rare diseases. Renowned for its innova..
>Volltext.. |
| 1313.21 Mio. EUR |
| 1713.92 Mio. EUR |
| 504.07 Mio. EUR |
| 65.05 Mio. EUR |
| -7.38 Mio. EUR |
| -0.04 EUR |
| 574.07 Mio. EUR |
| 71.14 Mio. EUR |
| 42 Mio. EUR |
| 1.12 |
| 37.94% |
| 93.27% |
| - |
| - |
| - |
| - |
| BIOCRYST |
| 13.02.26 |